Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Better Influenza Vaccines for the Elderly: Characterization of a Plant-made Virus-Like-Particle Candidate
FY 2015-16
Summary
Influenza viruses cause worldwide epidemics that result in approximately 3 to 5 million cases of severe illness and about 250 000 to 500 000 deaths annually, including 300 to 600 fatal cases in Canada. Complications mainly occur in the elderly and in infants. Older adults often mount weak immune responses to antigens, which partly explains their poor protection following vaccination with commercial intramuscular (IM) influenza split vaccines. It is important to learn more about the immunosenescent response to vaccines in order to develop new vaccination strategies to induce better protection for this vulnerable population. Different routes of administration have been demonstrated to influence both the magnitude and pattern of the immune response and immune responses at some anatomical sites (eg: respiratory mucosa or intranasal (IN)) may be better preserved in the elderly. Influenza virus-like-particles (VLPs) produced in plants are more immunogenic than classical split-virus formulations. We hypothesize that older subjects may be better protected by VLP vaccination delivered IN or by combining vaccination strategies in novel ways. The main objective of this work is to develop a better influenza vaccination strategy for the elderly based on an aged mouse model and a monovalent H1-bearing VLP. The specific aims of the study are therefore 1) to compare the protection provided by different routes of VLP immunization in aged mice 2) to establish the immune correlates of protection in mice at different ages, 3) better understand the effect of age on the immune response and its impacts on vaccine efficacy. We hope that this project will define a vaccination strategy for the elderly that will provide better protection against influenza viruses.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
350091
Name
Hodgins Breanna
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Better Influenza Vaccines for the Elderly: Characterization of a Plant-made Virus-Like-Particle Candidate
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Different Routes Of Vaccination; Elderly; H1n1; Immunology; Immunosenescence; Infectious Diseases; Influenza; Influenza Vaccines; Vaccines; Virus-Like-Particles
Abstract
Influenza viruses cause worldwide epidemics that result in approximately 3 to 5 million cases of severe illness and about 250 000 to 500 000 deaths annually, including 300 to 600 fatal cases in Canada. Complications mainly occur in the elderly and in infants. Older adults often mount weak immune responses to antigens, which partly explains their poor protection following vaccination with commercial intramuscular (IM) influenza split vaccines. It is important to learn more about the immunosenescent response to vaccines in order to develop new vaccination strategies to induce better protection for this vulnerable population. Different routes of administration have been demonstrated to influence both the magnitude and pattern of the immune response and immune responses at some anatomical sites (eg: respiratory mucosa or intranasal (IN)) may be better preserved in the elderly. Influenza virus-like-particles (VLPs) produced in plants are more immunogenic than classical split-virus formulations. We hypothesize that older subjects may be better protected by VLP vaccination delivered IN or by combining vaccination strategies in novel ways. The main objective of this work is to develop a better influenza vaccination strategy for the elderly based on an aged mouse model and a monovalent H1-bearing VLP. The specific aims of the study are therefore 1) to compare the protection provided by different routes of VLP immunization in aged mice 2) to establish the immune correlates of protection in mice at different ages, 3) better understand the effect of age on the immune response and its impacts on vaccine efficacy. We hope that this project will define a vaccination strategy for the elderly that will provide better protection against influenza viruses.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hodgins, Breanna
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~